Abstract:Background: Heme oxygenase (HO)-1, a stress-induced heat shock protease, has been implicated in the occurrence and progression of various tumors, though its impact on osteosarcoma remains unclear. This study aimed to elucidate the role of the HO-1 gene in regulating apoptosis in osteosarcoma cells and its associated mechanism. Method: Initially, bioinformatics analysis was employed to analyze the expression of HO-1 in osteosarcoma. Subsequently, human osteosarcoma cells (MG63 and HOS cell lines) were cultured in vitro to establish osteosarcoma cells transfected with adenovirus overexpressing HO-1. Cell activity was assessed using cell counting kit-8 (CCK-8) and colony formation assays. Western blotting was utilized to analyze levels of HO-1, microtubule-associated proteins light chain 3 (LC3), recombinant nucleoporin 62 (P62), transcription factor P65 (P65), B-cell lymphoma-2 (Bcl-2), Bcl-2 assaciated X protein (Bax), cleaved caspase-3, beta-actin, and phosphorylation p65 (P65-RelA). Flow cytometry was conducted to examine distribution of cell cycle and cell apoptosis. Transmission electron microscopy (TEM) was employed to detect autophagy, while immunofluorescence was used to observe P65-RelA nuclear expression. Additionally, apoptosis of osteosarcoma cells was assessed via terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. Knockdown of P62 and treatment with an nuclear factor-k-gene binding (NF-kappa B) inhibitor (PDTC) preceded Western blotting analysis, and apoptosis was evaluated using TUNEL staining. P65-RelA levels were assessed through immunofluorescence assay. Finally, a tumor-bearing nude mouse model was employed to validate the role of HO-1 in osteosarcoma in vivo. Results: The GSE11414 and GSE12865 chips were selected from the Gene Expression Omnibus (GEO) database and analyzed using the GEO 2R tool. The results indicated low expression of HO-1 in osteosarcoma. An in vitro osteosarcoma cell model with HO-1 overexpression was successfully established. Overexpression of HO-1 inhibited autophagic flow, promoted apoptosis in MG63 and HOS cells (p < 0.001), and reduced cell proliferation. Immunofluorescence analysis revealed an elevation in P65-RelA nuclear levels. Furthermore, transmission electron microscopy showed a significant reduction in the number of autophagic lysosomes. This phenomenon was reversed by pyrrolidine dithiocarbamate (PDTC) and siRNA-P62. Animal experiments confirmed the inhibitory effect of HO-1 on osteosarcoma. Conclusion: HO-1 is downregulated in osteosarcoma. HO-1 impairs autophagic flux in osteosarcoma cells, leading to the accumulation of P62, which activates apoptosis through the P62/RelA pathway and inhibits osteosarcoma tumorigenesis and progression.

Paclitaxel Induces Apoptosis in Osteosarcoma Via Promoting the Production of Reactive Oxygen Species and Inhibiting the Expression of Cyclooxygenase-2

Induction of Apoptosis by a Combination of Paclitaxel and Carboplatin in the Presence of Hyperthermia.

Cyclooxygenase-2 inhibitors induce anoikis in osteosarcoma via PI3K/Akt pathway.

Enhancement of Osteosarcoma Cell Sensitivity to Cisplatin Using Paclitaxel in the Presence of Hyperthermia

Paclitaxel-induced Apoptosis in Osteosarcoma Cell Line U-2 OS.

Paclitaxel Induces Apoptosis Via Caspase-3 Activation in Human Osteogenic Sarcoma Cells (U-2 Os)

Honokiol Induces Apoptosis and Autophagy Via the ROS/ERK1/2 Signaling Pathway in Human Osteosarcoma Cells in Vitro and in Vivo.

Paeoniflorin induces G2/M cell cycle arrest and caspase-dependent apoptosis through the upregulation of Bcl-2 X-associated protein and downregulation of B-cell lymphoma 2 in human osteosarcoma cells.

Effect of Paclitaxel on Apoptosis and bcl-2,bax Gene Expression in Human Osteosarcoma Cell

Tetrandrine induces apoptosis and triggers a caspase cascade in U2-OS and MG-63 cells through the intrinsic and extrinsic pathways.

Celecoxib Enhances Anticancer Effect of Cisplatin and Induces Anoikis in Osteosarcoma Via PI3K/Akt Pathway.

Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.

The Cyclooxygenase-2 Inhibitor NS-398 Inhibits Proliferation and Induces Apoptosis in Human Osteosarcoma Cells Via Downregulation of the Survivin Pathway.

Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition

Paclitaxel Induces the Apoptosis of Prostate Cancer Cells via ROS-Mediated HIF-1α Expression

Isoalantolactone inhibits constitutive NF-κB activation and induces reactive oxygen species-mediated apoptosis in osteosarcoma U2OS cells through mitochondrial dysfunction.

Metabolism Of Reactive Oxygen Species In Osteosarcoma And Potential Treatment Applications

Effects of Hypoxia on Proliferation and Apoptosis of Osteosarcoma Cells

HO-1 Regulates the Apoptosis of Osteosarcoma Cells Through the P62/RelA Signaling Axis

Bortezomib Sensitizes Human Osteosarcoma Cells to Adriamycin‐induced Apoptosis Through ROS‐dependent Activation of P‐eif2α/atf4/chop Axis

Experimental study of prediction of p21?actived kinase 5 on chemosensitivity of osteosarcoma